ACO Name and Location
Loudoun Medical Group ACO LLC
Previous Names: N/A
224D Cornwall St NW
Ste 403
Leesburg, VA 20176
ACO Primary Contact
Primary Contact Name | Mary Beth Tamasy, CEO |
Primary Contact Phone Number | 703-737-6006 |
Primary Contact Email Address | mtamasy@lmgdoctors.com |
Organizational Information
ACO Participants | ACO Participant in Joint Venture (Enter Y or N) |
Loudoun Medical Group PC | N |
ACO Governing Body:
Member | Member’s Voting Power* | Membership Type | ACO Participant** | ||
Last Name | First Name | Title/Position | |||
Crowley, MD | Anthony | Chairman | 1.00 | ACO Participant Representative | Loudoun Medical Group PC |
Calihan, MD | Martha | Voting Member | 1.00 | ACO Participant Representative | Loudoun Medical Group PC |
Kuo, MD | Michael | Voting Member | 1.00 | ACO Participant Representative | Loudoun Medical Group PC |
Hetzel, MD | Robert | Voting Member | 1.00 | ACO Participant Representative | Loudoun Medical Group PC |
Mellis, MD | Michael G. | Voting Member | 1.00 | ACO Participant Representative | Loudoun Medical Group PC |
Beloy, MD | Amie | Voting Member | 1.00 | ACO Participant Representative | Loudoun Medical Group PC |
Nekoba, MD | Jeffrey | Voting Member | 1.00 | ACO Participant Representative | Loudoun Medical Group PC |
Thompson, MD | Jennifer B. | Voting Member | 1.00 | ACO Participant Representative | Loudoun Medical Group PC |
Akhtar, MD | Nauman | Voting Member | 1.00 | ACO Participant Representative | Loudoun Medical Group PC |
Tamasy | Mary Beth | Voting Member | 1.00 | ACO Participant Representative | Loudoun Medical Group PC |
Kearns | Kathryn | Voting Member | 1.00 | Medicare Beneficiary Representative | Loudoun Medical Group PC |
* Expressed as a percentage or number
** Legal Business Name/DBA, if Applicable
Key ACO Clinical and Administrative Leadership:
Mary Beth Tamasy | ACO Executive |
Anthony Crowley | Medical Director |
Clara Nussbaum | Compliance Officer |
Clara Nussbaum | Quality Assurance/Improvement Officer |
Associated Committees and Committee Leadership:
Quality Assurance and Improvement Committee – Anthony Crowley, MD, Chair
Finance Committee – Robert Hetzel, MD, Chair
Communications Committee – Linda Coleman, MD, Chair
Types of ACO participants, or combinations of participants, that formed the ACO:
- ACO professionals in a group practice arrangement
Amount of Shared Savings/Losses:
- Third Agreement Period
- Performance Year 2020, $0
- Second Agreement Period
- Performance Year 2019, $0
- Performance Year 2018, $0
- Performance Year 2017, $1,272,644
- Second Agreement Period
- Performance Year 2016, $0
- Performance Year 2015, $0
- Performance Year 2014, $0
Shared Savings Distribution:
- Third Agreement Period
- Performance Year 2020
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2020
- Second Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants N/A
- Performance Year 2018
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2017
- Proportion invested in infrastructure: 30%
- Proportion invested in redesigned care processes/resources: 30%
- Proportion of distribution to ACO participants: 40%
- Performance Year 2019
- First Agreement Period
- Performance Year 2016
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2015
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2014
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2016
Quality Performance Results
2020 Quality Performance Results:
You may need to scroll horizontally to view all of the data.
2020 Quality Performance Results:
ACO # | Measure Name | Rate | ACO Mean |
ACO-43 | Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) | 0.94 | 0.95 |
ACO-13 | Falls: Screening for Future Fall Risk | 77.60 | 84.97 |
ACO-14 | Preventive Care and Screening: Influenza Immunization | 66.80 | 76.03 |
ACO-17 | Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention | 28.57 | 81.67 |
ACO-18 | Preventive Care and Screening: Screening for Depression and Follow-up Plan | 31.34 | 71.46 |
ACO-19 | Colorectal Cancer Screening | 65.56 | 72.59 |
ACO-20 | Breast Cancer Screening | 57.58 | 74.05 |
ACO-42 | Statin Therapy for the Prevention and Treatment of Cardiovascular Disease | 81.50 | 83.37 |
ACO-27 | Diabetes Mellitus: Hemoglobin A1c Poor Control | 12.25 | 14.70 |
ACO-28 | Hypertension (HTN): Controlling High Blood Pressure | 69.20 | 72.87 |
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.